Medications &
Hair Loss

Introduction

Hair loss can be an emotionally taxing experience, and one that often leaves individuals searching for answers in their diet, hormones, or genetics. Yet one often-overlooked contributor sits quietly in the medicine cabinet: prescription and over-the-counter medications.

This article outlines a comprehensive and medically informed list of medications known to contribute to various forms of hair loss.

When paired with personalized assessments and advanced diagnostics, identifying drug-induced hair loss is often the key that unlocks a successful long-term treatment strategy.

Mechanisms of Action

The human scalp contains over 100,000 hair follicles, each operating in its own growth cycle: anagen (growth), catagen (transition), and telogen (resting).

In trichology, we categorize medication-induced hair into several mechanisms.

Anagen Effluvium

This form of hair loss occurs when medication disrupts cells in the active growth phase. Hair follicles in anagen are metabolically active and rapidly dividing, making them particularly susceptible to drugs that interfere with replication or mitosis1.

Hair loss appears quickly, typically within days to weeks of drug initiation, and can result in near-total scalp hair loss.

Telogen Effluvium

Telogen effluvium is more insidious and often goes unrecognized until weeks or even months after a new medication is started.

Here, the drug induces a premature shift of growing anagen hairs into the resting telogen phase. Roughly 6 to 12 weeks later, diffuse shedding becomes noticeable2.

This hair loss is associated with medications that send stress signals to the follicular microenvironment.

Hormonal Disruption

Several medications exert indirect effects on hair follicles by altering endocrine function. The result can mimic androgenetic alopecia or worsen existing predispositions3.

Nutrient Depletion

Many drugs inhibit absorption of key nutrients such as zinc, biotin, iron, and B-vitamins—all essential for keratin production, follicular cycling, and mitochondrial function4.

Inflammation and Oxidative Stress

Some medications, especially those metabolized in the liver or affecting immune pathways, can contribute to systemic inflammation.

This increase in inflammatory cytokines can impair dermal microcirculation and alter signaling in the follicular stem cell5.

Hormonal Therapy and Endocrine Modulators

Hormonal balance plays a critical role in the regulation of the hair growth cycle.

Anti-Androgens and Hormone Replacement Therapies

Drugs that suppress or modulate testosterone can be therapeutic in cases of androgenic alopecia (especially in females), but they may also paradoxically trigger shedding when the body’s hormonal equilibrium is disrupted.

Testosterone Replacement Therapy (TRT)

Increasing systemic androgens accelerates miniaturization of androgen-sensitive follicles. Hairline recession and crown thinning are commonly observed in those undergoing TRT12.

Finasteride / Dutasteride

Though prescribed to treat male-pattern hair loss, these DHT blockers can trigger temporary shedding during the adjustment phase13.

GnRH agonists and antagonists

Used in prostate cancer and endometriosis, they can lower systemic sex hormone levels significantly, leading to thinning14.

Contraceptives and Fertility Medications

Follicles are sensitive to estrogen and progesterone fluctuations, particularly in the transition off or onto contraceptives.

Levonorgestrel IUDs

Associated with diffuse shedding in sensitive individuals due to systemic absorption of progestin15.

Clomiphene (Clomid) and Letrozole

Fertility medications that alter estrogen feedback may cause temporary hair loss related to hormonal cycling and stress16.

Endocrine Therapies in Cancer

Tamoxifen and aromatase inhibitors (e.g., anastrozole, letrozole) are cornerstone treatments in hormone-receptor-positive breast cancer.

Reduced estrogen levels can thin hair, particularly in frontal and temporal areas. This pattern is often seen in postmenopausal hair loss17.

Anticoagulants

Blood thinners can increase the risk of telogen effluvium.

The mechanism may involve18:

• Altered microvascular perfusion
• Disruption of follicular nutrient supply (Vitamin K)

Warfarin and Heparin

Warfarin is a vitamin K antagonist, and heparin enhances antithrombin III activity.

Hair shedding often begins 6–12 weeks after treatment initiation and may be reversible upon discontinuation or dosage reduction.

Heparin-induced shedding is often more rapid and dramatic, particularly in hospitalized patients receiving high-dose unfractionated formulations.

Direct Oral Anticoagulants (DOACs)

Apixaban, rivaroxaban, dabigatran, and edoxaban have also been associated with hair loss, although data is limited.

While the incidence appears lower, DOACs may still disrupt dermal capillary perfusion or alter follicular signaling indirectly19.

Psychiatric Medications

Patients undergoing treatment for mood, anxiety, or bipolar disorders report diffuse shedding, which can worsen psychosocial distress and treatment hesitancy.

SSRIs

Selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine (Prozac) and sertraline (Zoloft) can lead to telogen effluvium.

The proposed mechanism involves25:

• Altered serotonergic/noradrenergic signaling in the hypothalamic-pituitary axis.

• Stress pathway modulation, affecting follicular cycling.

Hair loss emerges within the first 1–3 months of initiation or after dose increases.

Switching between SSRIs or lowering the dosage often leads to resolution of shedding within 3–6 months.

Mood Stabilizers

Lithium, a frontline treatment for bipolar disorder, is a well-documented culprit of drug-induced hair loss. The mechanisms may involve26:

• Disruption of thyroid hormone levels.

• Direct toxic effects on matrix keratinocytes at the follicle base.

Other antiepileptic mood stabilizers such as valproic acid (Depakote) and carbamazepine have also shown hair loss side effects, potentially due to27,28:

• Folate depletion

• Biotin deficiency

• Altered mitochondrial function

Blood Pressure Medications

Hypertension medications are among the most prescribed drugs globally.

While essential for cardiovascular health, patients may not immediately link hair shedding to blood pressure control, so this side effect often goes unrecognized.

Beta Blockers

Propranolol, metoprolol, and atenolol are used in treating hypertension, arrhythmias, and anxiety. Several observational reports and case series have linked beta blockers to29:

• Follicular miniaturization via reduced peripheral circulation

• Telogen effluvium, likely due to alteration of the hair growth cycle

Some individuals are more sensitive to sympathetic nervous system suppression, resulting in early shedding within 6–12 weeks of initiating therapy.

The shedding is generally mild and self-limiting.

ACE Inhibitors and ARBs

Angiotensin-converting enzyme (ACE) inhibitors (lisinopril, enalapril, and ramipril)30, along with angiotensin II receptor blockers (ARBs) (losartan), have also been occasionally associated with TE. The hypothesized mechanisms include:

• Altered perifollicular blood flow

• Potential downstream effects on bradykinin, a peptide involved in inflammatory

modulation31

Immunosuppressants and Biologics

Drugs that modulate immune activity can have dual effects on the hair follicle: some may cause hair loss, while others can support regrowth in autoimmune conditions like alopecia areata.

Cyclosporine and Methotrexate

Cyclosporine, used in transplant patients and autoimmune disorders, can cause both hirsutism and telogen effluvium, depending on dosage and duration40,41.

Methotrexate, a folate antagonist, can disrupt42:

• DNA synthesis in the hair matrix

• Nutrient absorption and gut mucosal integrity

Hair loss from these drugs is often dose-dependent and reversible.

Biologics (TNF-alpha inhibitors, IL-inhibitors)

Adalimumab43 or infliximab44, used for psoriasis and Crohn’s disease, can lead to diffuse shedding or exacerbate pre-existing alopecia.

The suppression of cytokines like TNF-alpha, which regulates the hair cycle, interferes with the anagen phase45.

In some cases, like with JAK inhibitors (tofacitinib), significant regrowth has been observed in alopecia areata, pointing to a nuanced and context-specific effect of immune-modulating therapies on hair biology46.

Thyroid Medications

Thyroid hormones play a central role in regulating metabolic rates and hair follicle cycling.

Levothyroxine

While prescribed to restore normal thyroid function, levothyroxine can cause paradoxical shedding if dosed too aggressively or inadequately47. The reasons include:

• Imbalanced T3/T4 ratios, impacting follicular metabolism

• Abrupt shifts in metabolic rate, shocking follicles into telogen

Patient Guidance

Medication-induced hair loss is a complex but often overlooked phenomenon.

Not all medication-related hair loss requires discontinuation. In many cases, shedding is:

• Self-limited, resolving once the body adjusts

• Secondary to nutrient or gut disruption, which may be corrected

• Exacerbated by stress or genetic predisposition

At Advanced Trichology, we recommend a multifactorial approach:

• Review all medications and supplements with a qualified provider

• Conduct comprehensive testing

• Consider stool analysis or GI assessments

• Use evidence-based protocols aligned with the Gaunitz Trichology Method

(GTM)

If hair loss coincides with a new prescription or medication adjustment, document the timing and consult both your prescribing physician and a certified trichologist.

A collaborative, root-cause strategy ensures that necessary treatments are maintained while mitigating the impact on hair and scalp health.